GlassScriptPhysician profile
Travis David Hansen
NPI 1164558151
$357.81
in general payments reported to CMS, 2019-2025
10 companies · $27.80 in 2025
The $27.80 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.61 · 2022: $26.96 · 2023: $93.70 · 2024: $148 · 2025: $27.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $129.45 | 2021-2025 | Qelbree, Qelbree |
| Neuronetics, INC. | $63.86 | 2024 | Neurostar Tms Therapy System |
| Acadia Pharmaceuticals INC | $33.15 | 2023-2024 | Nuplazid |
| Corium, LLC | $29.19 | 2023-2024 | Azstarys |
| Alkermes, INC. | $24.39 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $19.05 | 2023 | Uzedy |
| Abbvie INC. | $15.32 | 2022 | |
| Novo Nordisk INC | $15.26 | 2023 | |
| Almatica Pharma LLC | $14.82 | 2021 | |
| Harmony Biosciences LLC | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.